LISCure Biosciences

Seongnam, South Korea · Founded 2018 · Privately Held (backing)

Developer of bacteria-mediated immunotherapy designed to treat tumors as well as cancer. LISCure Biosciences is based in Seongnam, South Korea and was founded in 2018. It has raised $47.5 million.

Last price · $/share

—

Implied valuation

—

Total raised

$47.5M

Last round

—

How much has LISCure Biosciences raised?

$47.5Macross 0 recorded rounds

Free account

More of LISCure Biosciences with a free account

·The complete investor list: 18 names
·Watch LISCure Biosciences: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

LISCure Biosciences investors

18 investors are on record for LISCure Biosciences, including KB Investment, Mayo Clinic, Yuanta Investment and Shinhan Securities.

For fundraisers

Raising for a company like LISCure Biosciences?

18 investors have backed LISCure Biosciences.

See all 18 investors →

Frequently asked about LISCure Biosciences

How much has LISCure Biosciences raised?: LISCure Biosciences has raised $47.5M in total across 0 recorded funding rounds.